SARS CoV-2 infection among Healthcare Workers from different public health units in Brazil

Mol Immunol. 2023 Nov:163:13-19. doi: 10.1016/j.molimm.2023.09.001. Epub 2023 Sep 15.

Abstract

Understanding COVID-19 exposure differences among Healthcare Workers (HCWs) across various healthcare units is crucial for their protection and effective management of future outbreaks. However, comparative data on COVID-19 among HCWs in different healthcare units are scarce in Brazil. This study evaluated the relationship between SARS-CoV-2 infection and workplaces in HCWs from three distinct healthcare settings in Brazil. It also examined COVID-19 symptom dynamics reported by them. The cohort comprised 464 HCWs vaccinated with two doses of CoronaVac and a BNT162b2 booster from different institutions: Primary Health Care Units (PHCUs), Emergency Care Units (ECUs), and Hospitals. Participants answered a questionnaire and underwent blood collection at various time points after vaccinations. RT-PCR data and post-vaccination antibody responses were utilized as indicators of SARS-CoV-2 infection. We found that most infected HCWs worked in ECUs, where positive RT-PCR percentages were higher compared to PHCUs and Hospitals. ECUs also showed the highest seropositivity and antibody levels, especially after the first CoronaVac dose. The second dose of CoronaVac diminished the differences in the antibody levels among HCWs from ECUS, PHCUs, and Hospitals, indicating the benefit of the second dose to equalize the antibody levels between previously exposed and unexposed persons. Moreover, COVID-19 symptoms appeared to evolve over time.

Keywords: Care units; Healthcare professionals; SARS-CoV-2 infection, post- vaccination antibody response, COVID-19 symptoms; Unified Health System.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • Brazil / epidemiology
  • COVID-19*
  • Health Personnel
  • Humans
  • Public Health*
  • SARS-CoV-2

Substances

  • sinovac COVID-19 vaccine
  • BNT162 Vaccine
  • Antibodies, Viral